Fiona Stevens, Partner, Gill Jennings & Every to Speak at the Knowledge Group’s Strategic Patent Portfolio and Lifecycle Development for Pharma & Biotech Industries Event
Fiona Stevens, Partner, Gill Jennings & Every to Speak at the Knowledge Group’s Strategic Patent Portfolio and Lifecycle Development for Pharma & Biotech Industries in 2016 Live Webcast
New York, NY, January 19, 2016 --(PR.com)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Fiona Stevens, Partner, Gill Jennings & Every will speak at the Knowledge Group’s webcast entitled: “Strategic Patent Portfolio and Lifecycle Development for Pharma & Biotech Industries in 2016.” This event is scheduled for March 29, 2016 from 12:00pm – 2:00pm (ET).
For further details, please visit: https://theknowledgegroup.org/strategic-patent-portfolio-and-lifecycle-development-for-pharma-biotech-industries-in-2016-live-webcast-2/
About Fiona Stevens
Fiona Stevens is a European Patent Attorney at Gill Jennings & Every and handles a wide variety of work in the pharmaceutical, chemical and biotechnology fields. She has a Masters degree in Natural Sciences (chemistry, pharmacology and physiology) from the University of Cambridge.
The majority of Fiona’s clients are UK SMEs, primarily in the Biotechnology and Pharmaceutical industries. She has extensive experience helping companies create and shape their IP strategies and worldwide patent portfolios, and specialises in helping her clients get “due diligence ready.” Fiona has guided her clients through multiple fund-raising rounds and partnering processes, helping them raise well in excess of £200 million in the last two years alone. Fiona ardently believes that there is no “one size fits all” approach to IP strategy, but rather helps tailor the strategy according to the business plan.
Fiona has a particular interest in protecting re-profiled drugs via second medical use patents, and is on a mission to educate big pharma and investors as to their value, which is commonly misunderstood. Fiona has obtained many second medical use patents (and supplementary protection certificates) on compounds that are now successful drugs.
About Gill Jennings & Every LLP
Gill Jennings & Every LLP is a leading European intellectual property firm based in London. It represents the patent, trade mark and design interests of many prominent British, European and global corporations and helps guide high-growth SMEs as they seek to establish a presence in fiercely competitive markets. It understands the strategic importance of intellectual property to any business by providing clear, creative and expert advice and assists businesses in protecting, exploiting and managing IP assets to maximise their true market value.
Gill Jennings & Every is consistently recognised by the leading UK legal directories, Chambers, Legal 500 and Managing Intellectual Property as a top tier 'go-to' firm, which is a testament to the quality of advice and support it provides to its clients.
For more information, please see http://www.gje.com/
Event Synopsis:
The relentless transformation of generic competition seems to pose a threat for pharma and biotech lifecycles. With its growing complexity, companies with poor product lifecycle management strategies are more likely to be exposed to legal challenges and revenue risks. Thus, it is crucial for companies to establish and maintain a robust life cycle management strategy to minimize possible loss and liabilities.
In a two-hour live Webcast, a panel of key thought leaders, professionals and regulators assembled by The Knowledge Group will help the audience understand the most significant issues with respect to portfolio strategies in pharmaceutical and biotechnology patent lifecycle management and development. The panel will also share their expertise and insights on how to best maintain an effective and efficient patent portfolio in biotech and pharma lifecycle.
Key topics include:
− Pharmaceutical and Biotechnology Patent Life Cycles – An Overview
− Patent Term Adjustments for Biotech and Pharma
− Role of PTA in Biotech and Pharma Patent Life Cycle
− Patent Term Extensions
− Patentability and Implications for Life Sciences Innovation
− Portfolio Strategies
− Common Risks and Pitfalls
− Up-to-the-minute Regulatory Updates
About The Knowledge Group/The Knowledge Congress Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/
For further details, please visit: https://theknowledgegroup.org/strategic-patent-portfolio-and-lifecycle-development-for-pharma-biotech-industries-in-2016-live-webcast-2/
About Fiona Stevens
Fiona Stevens is a European Patent Attorney at Gill Jennings & Every and handles a wide variety of work in the pharmaceutical, chemical and biotechnology fields. She has a Masters degree in Natural Sciences (chemistry, pharmacology and physiology) from the University of Cambridge.
The majority of Fiona’s clients are UK SMEs, primarily in the Biotechnology and Pharmaceutical industries. She has extensive experience helping companies create and shape their IP strategies and worldwide patent portfolios, and specialises in helping her clients get “due diligence ready.” Fiona has guided her clients through multiple fund-raising rounds and partnering processes, helping them raise well in excess of £200 million in the last two years alone. Fiona ardently believes that there is no “one size fits all” approach to IP strategy, but rather helps tailor the strategy according to the business plan.
Fiona has a particular interest in protecting re-profiled drugs via second medical use patents, and is on a mission to educate big pharma and investors as to their value, which is commonly misunderstood. Fiona has obtained many second medical use patents (and supplementary protection certificates) on compounds that are now successful drugs.
About Gill Jennings & Every LLP
Gill Jennings & Every LLP is a leading European intellectual property firm based in London. It represents the patent, trade mark and design interests of many prominent British, European and global corporations and helps guide high-growth SMEs as they seek to establish a presence in fiercely competitive markets. It understands the strategic importance of intellectual property to any business by providing clear, creative and expert advice and assists businesses in protecting, exploiting and managing IP assets to maximise their true market value.
Gill Jennings & Every is consistently recognised by the leading UK legal directories, Chambers, Legal 500 and Managing Intellectual Property as a top tier 'go-to' firm, which is a testament to the quality of advice and support it provides to its clients.
For more information, please see http://www.gje.com/
Event Synopsis:
The relentless transformation of generic competition seems to pose a threat for pharma and biotech lifecycles. With its growing complexity, companies with poor product lifecycle management strategies are more likely to be exposed to legal challenges and revenue risks. Thus, it is crucial for companies to establish and maintain a robust life cycle management strategy to minimize possible loss and liabilities.
In a two-hour live Webcast, a panel of key thought leaders, professionals and regulators assembled by The Knowledge Group will help the audience understand the most significant issues with respect to portfolio strategies in pharmaceutical and biotechnology patent lifecycle management and development. The panel will also share their expertise and insights on how to best maintain an effective and efficient patent portfolio in biotech and pharma lifecycle.
Key topics include:
− Pharmaceutical and Biotechnology Patent Life Cycles – An Overview
− Patent Term Adjustments for Biotech and Pharma
− Role of PTA in Biotech and Pharma Patent Life Cycle
− Patent Term Extensions
− Patentability and Implications for Life Sciences Innovation
− Portfolio Strategies
− Common Risks and Pitfalls
− Up-to-the-minute Regulatory Updates
About The Knowledge Group/The Knowledge Congress Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/
Contact
The Knowledge Group
Thomas LaPointe, Jr., Executive Director
646-844-0200
www.theknowledgegroup.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Thomas LaPointe, Jr., Executive Director
646-844-0200
www.theknowledgegroup.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Contact
Categories